Core & Main CNM
$40.45 −$1.22 (-2.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $40.45 0.00%
Open$41.52
Prev close$41.67
Day range$40.37 – $42.28
Volume2.10M
Market cap$7.45B
P/E (TTM)16.6
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Aug 2026
Revenue$2.15B+2.5% YoY
Operating profit$227.00M+6.6% YoY
Net profit$150.00M+6.4% YoY
Diluted EPS$0.77+10.0% YoY
Free cash flow$44.00M+83.3% YoY
Operating cash flow$62.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin27.0%
Operating margin9.6%
Net margin6.0%
Return on equity23.4%
Return on assets7.1%
Return on invested capital11.9%
Current ratio2.47
Liabilities / assets68.6%
Cash & investments$312.00M
Total debt$2.67B
Net cash (debt)-$2.36B
Free cash flow / sales8.2%
Where the revenue comes from
Quarter 2027/Q2
By business line
Income statement
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $2.15B | $1.91B | $7.65B | $1.58B | $2.06B |
| Total Operating Revenue | $2.15B | $1.91B | $7.65B | $1.58B | $2.06B |
| Cost of Revenue | $1.57B | $1.39B | $5.59B | $1.15B | $1.50B |
| Gross Profit | $573.00M | $520.00M | $2.06B | $428.00M | $561.00M |
| Operating Expense | $346.00M | $343.00M | $1.34B | $310.00M | $341.00M |
| Selling and Admin Expenses | $301.00M | $299.00M | $1.15B | $264.00M | $295.00M |
| Depreciation & Amortization & Depletion | $45.00M | $44.00M | $183.00M | $46.00M | $46.00M |
| -Depreciation & Amortization | $45.00M | $44.00M | $183.00M | $46.00M | $46.00M |
| Operating Profit | $227.00M | $177.00M | $722.00M | $118.00M | $220.00M |
| Net Non-Operating Interest Income (Expense) | -$32.00M | -$27.00M | -$120.00M | -$29.00M | -$30.00M |
| Non-Operating Interest Expense | $32.00M | $27.00M | $120.00M | $29.00M | $30.00M |
| Other Income (Expense) | -$2.00M | – | $5.00M | – | – |
| Other Non-Operating Income (Expenses) | -$2.00M | – | $5.00M | – | – |
| Pretax Profit | $193.00M | $150.00M | $607.00M | $94.00M | $190.00M |
| Tax | $43.00M | $37.00M | $145.00M | $21.00M | $47.00M |
| Net Profit | $150.00M | $113.00M | $462.00M | $73.00M | $143.00M |
| Profit from Continuing Operations | $150.00M | $113.00M | $462.00M | $73.00M | $143.00M |
| Minority Interests | $6.00M | $5.00M | $21.00M | $3.00M | $6.00M |
| Net Income to Parent Company | $144.00M | $108.00M | $441.00M | $70.00M | $137.00M |
| Net Income to Common Stockholders | $144.00M | $108.00M | $441.00M | $70.00M | $137.00M |
| Basic EPS | $0.77 | $0.57 | $2.32 | $0.37 | $0.72 |
| Diluted EPS | $0.77 | $0.57 | $2.31 | $0.37 | $0.72 |
Balance sheet
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Assets | $6.71B | $6.32B | $6.09B | $6.09B | $6.30B |
| Total Current Assets | $2.94B | $2.56B | $2.30B | $2.30B | $2.51B |
| Cash and Cash Equivalents & Short-Term Investments | $312.00M | $150.00M | $220.00M | $220.00M | $89.00M |
| -Cash and Cash Equivalents | $312.00M | $150.00M | $220.00M | $220.00M | $89.00M |
| Receivables | $1.44B | $1.26B | $1.05B | $1.05B | $1.34B |
| -Accounts Receivable | $1.36B | $1.20B | $981.00M | $981.00M | $1.24B |
| -Other Receivables | $76.00M | $63.00M | $67.00M | $67.00M | $98.00M |
| Inventory | $1.14B | $1.10B | $986.00M | $986.00M | $1.02B |
| Other Current Assets | $49.00M | $45.00M | $48.00M | $48.00M | $60.00M |
| Total Non-Current Assets | $3.77B | $3.77B | $3.78B | $3.78B | $3.79B |
| Net PPE | $489.00M | $481.00M | $465.00M | $465.00M | $455.00M |
| -Gross PPE | $489.00M | $481.00M | $666.00M | $666.00M | $455.00M |
| Goodwill and Other Intangible Assets | $2.68B | $2.71B | $2.74B | $2.74B | $2.77B |
| -Goodwill | $1.92B | $1.92B | $1.92B | $1.92B | $1.92B |
| -Other Intangible Assets | $759.00M | $791.00M | $823.00M | $823.00M | $847.00M |
| Non-Current Deferred Assets | $552.00M | $561.00M | $565.00M | $565.00M | $571.00M |
| Other Non-Current Assets | $51.00M | $13.00M | $10.00M | $10.00M | $2.00M |
| Total Liabilities | $4.61B | $4.21B | $4.01B | $4.01B | $4.25B |
| Total Current Liabilities | $1.19B | $1.11B | $874.00M | $874.00M | $1.11B |
| Payables | $815.00M | $814.00M | $512.00M | $512.00M | $734.00M |
| -Accounts Payable | $815.00M | $814.00M | $512.00M | $512.00M | $734.00M |
| Short-Term Debt and Capital Lease Obligation | $96.00M | $101.00M | $99.00M | $99.00M | $98.00M |
| -Current Debt | $17.00M | $24.00M | $24.00M | $24.00M | $24.00M |
| -Current Capital Lease Obligation | $79.00M | $77.00M | $75.00M | $75.00M | $74.00M |
| Other Current Liabilities | $190.00M | $126.00M | $140.00M | $140.00M | $168.00M |
| Total Non-Current Liabilities | $3.42B | $3.10B | $3.14B | $3.14B | $3.14B |
| Long Term Accounts Payable and Other Payables | $644.00M | $642.00M | $680.00M | $680.00M | $682.00M |
| Long Term Debt and Capital Lease Obligation | $2.65B | $2.34B | $2.34B | $2.34B | $2.34B |
| -Long Term Debt | $2.43B | $2.12B | $2.12B | $2.12B | $2.13B |
| -Long Term Capital Lease Obligation | $221.00M | $223.00M | $214.00M | $214.00M | $207.00M |
| Non-Current Deferred Liabilities | $90.00M | $89.00M | $89.00M | $89.00M | $89.00M |
| Other Non-Current Liabilities | $28.00M | $30.00M | $30.00M | $30.00M | $31.00M |
| Total Equity | $2.10B | $2.11B | $2.07B | $2.07B | $2.06B |
| Stockholders' Equity | $2.03B | $2.04B | $2.00B | $2.00B | $1.98B |
| Capital Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| -Common Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| Additional Paid-In Capital | $1.24B | $1.25B | $1.25B | $1.25B | $1.25B |
| Retained Earnings | $784.00M | $786.00M | $755.00M | $755.00M | $736.00M |
| Gains/Losses Not Affecting Retained Earnings | $3.00M | -$1.00M | -$6.00M | -$6.00M | -$6.00M |
| Minority Interests | $73.00M | $74.00M | $77.00M | $77.00M | $78.00M |
| -Accumulated Depreciation | – | – | -$201.00M | -$201.00M | – |
Cash flow
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $62.00M | $82.00M | $650.00M | $268.00M | $271.00M |
| Net cash flow from continuing operations | $62.00M | $82.00M | $650.00M | $268.00M | $271.00M |
| Net Income from Continuing Operations | $150.00M | $113.00M | $462.00M | $73.00M | $143.00M |
| Depreciation & Depletion & Amortization | $50.00M | $47.00M | $192.00M | $48.00M | $48.00M |
| Deferred Tax | $7.00M | $6.00M | $28.00M | $8.00M | $13.00M |
| Other Non-Cash Items | $4.00M | $2.00M | – | – | $3.00M |
| Change in Working Capital | -$153.00M | -$89.00M | -$49.00M | $146.00M | $60.00M |
| -Change in Receivables | -$184.00M | -$213.00M | $26.00M | $303.00M | $23.00M |
| -Change in Inventory | -$36.00M | -$119.00M | -$70.00M | $36.00M | $46.00M |
| -Change in Payables and Accrued Expense | $67.00M | $244.00M | -$11.00M | -$201.00M | -$12.00M |
| -Change in Other Current Assets | $0.00 | -$1.00M | $6.00M | $8.00M | $3.00M |
| Net cash flow from investing | -$35.00M | -$21.00M | -$145.00M | -$74.00M | -$43.00M |
| Net Cash Flow from Continuing Investing Activities | -$35.00M | -$21.00M | -$145.00M | -$74.00M | -$43.00M |
| Capital Expenditure | -$18.00M | -$14.00M | -$46.00M | -$15.00M | -$8.00M |
| Net Other Investing Changes | -$17.00M | -$7.00M | -$38.00M | -$30.00M | -$3.00M |
| Financing Cash Flow | $135.00M | -$131.00M | -$293.00M | -$63.00M | -$164.00M |
| Net Cash Flow from Continuing Financing Activities | $135.00M | -$131.00M | -$293.00M | -$63.00M | -$164.00M |
| Net Issuance Payments Of Debt | $318.00M | -$6.00M | -$117.00M | -$6.00M | -$106.00M |
| Net Common Stock Issuance | -$169.00M | -$88.00M | -$155.00M | -$58.00M | -$50.00M |
| Net Other Financing Charges | -$14.00M | -$37.00M | -$21.00M | $1.00M | -$8.00M |
| Ending Cash Balance | $312.00M | $150.00M | $220.00M | $220.00M | $89.00M |
| Net Change in Cash | $162.00M | -$70.00M | $212.00M | $131.00M | $64.00M |
| Beginning Cash Balance | $150.00M | $220.00M | $8.00M | $89.00M | $25.00M |
| Free Cash Flow | $44.00M | $68.00M | $604.00M | $253.00M | $263.00M |
| Net Business Purchase and Sale | – | – | -$61.00M | -$29.00M | – |
No comments yet — be the first to weigh in on CNM.
Sign in to join the discussion.